CRISPR AG (CRSP) gains 2.92% to Close at $121.25 on September 23


Today, CRISPR Therapeutics AG Inc’s (NASDAQ: CRSP) stock gained $3.44, accounting for a 2.92% increase. CRISPR AG opened at $118.84 before trading between $122.25 and $116.91 throughout Thursday’s session. The activity saw CRISPR AG’s market cap rise to $9,239,393,681 on 772,247 shares -below their 30-day average of 885,150.


About CRISPR Therapeutics AG

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc.CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.



Visit CRISPR Therapeutics AG’s profile for more information.



The Daily Fix



The Federal Aviation Administration (FAA) wants US passenger airlines to do more to address the surge in incidents involving unruly or violent passengers.


Food delivery service DoorDash will now support delivery of beer, wine and spirits across 20 US states, the District of Columbia, Canada and Australia, a move the company said could enable it to reach 100 million+ customers.


Breakthrough Energy, a non-profit launched by billionaire philanthropist and Microsoft (NASDAQ: MSFT) co-founder Bill Gates in 2016, has raised a warchest from seven leading global corporations to further the organization’s mission of reaching a net-zero emissions society by 2050. 




About The Nasdaq Stock Market





The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world’s leading exchange for options volume and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.



To get more information on CRISPR Therapeutics AG and to follow the company’s latest updates, you can visit the company’s profile page here: CRISPR Therapeutics AG’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.



Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: www.equities.com/disclaimer


President Biden Hosting Leaders From India, Japan, Australia Friday in First ‘Quad’ Summit
Some Chinese Banks Stop Offering New Credit to Property Developers Amid Evergrande Scare
Iowa Senator Chuck Grassley Seeks Eighth Term of Office
House Select Committee Subpoenas Four Trump Allies in US Capitol Riot Probe
CDC Endorses COVID-19 Vaccine Booster Shots for Millions of Older and Vulnerable Individuals
Semiconductor Shortage To Cost Global Auto Industry $210 Billion in Revenue in 2021
US Olympic Athletes Must Have COVID-19 Vaccination for Beijing Winter Games
FAA Urges Airlines To Take Stronger Action With Unruly, Disruptive Passengers


Read more here: Source link